The HDAC6 inhibitor ACY-1215 enhances the anticancer activity of oxaliplatin in colorectal cancer cells

Lee, DH; Won, HR; Ryu, HW; Han, JM; Kwon, SH

Kwon, SH (reprint author), Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, 85 Songdogwahak Ro, Incheon 21983, South Korea.

INTERNATIONAL JOURNAL OF ONCOLOGY, 2018; 53 (2): 844

Abstract

ACY-1215, also known as ricolinostat, is a leading histone deacetylase 6 inhibitor, which is currently being tested in clinical trials for hematologic......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索